Advertisement
U.S. markets open in 48 minutes

RAMM Pharma Corp. (RAMM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.03500.0000 (0.00%)
At close: 12:20PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0350
Open0.0000
Bid0.0300 x N/A
Ask0.0400 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume37,395
Market Cap4.179M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1700
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RAMM.CN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      RAMM Pharma Corp. Announces Corporate Update

      TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”). Each Unit would have been comprised of one common share in the capital of the Company (each, a “Common Share”), and one

    • GlobeNewswire

      RAMM Pharma Corp. Announces Clarification of its Corporate Update of September 12th

      TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to complete a non-brokered private placement of up to 20,000,000 units (the “Units”) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering”). Each Unit would have been comprised of one common share in the capital of the Company (each, a “Common Share”), and one

    • GlobeNewswire

      RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid

      TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it intends to complete a non-brokered private placement of up to 20,000,000 units (the "Units") of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the "Offering"). Each Unit shall be comprised of one common share in the capital of the Company (each, a “Common Share”), and one Common Share purchase warra